Información*
| Nombre | SUSANNA EDITH MEDELLIN GARIBAY |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | CIENCIAS MÉDICAS |
| Disciplina | FARMACOLOGÍA |
| Especialidad | FARMACOCINETICA |
| CVU | 265665 |
| Institución | |
|---|---|
| Dependencia | FACULTAD DE CIENCIAS QUIMICAS |
| Entidad | SAN LUIS POTOSI |
| Nivel | 2 |
| Vigencia | Inicio: 01/01/2023 |
| Fin: 31/12/2027 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2024
- External Evaluation of Population Pharmacokinetic Models of Piperacillin in Preterm and Term Patients from Neonatal Intensive Care European Journal of Drug Metabolism and Pharmacokinetics
- Comparison of pharmacokinetics software for therapeutic drug monitoring of piperacillin in patients with severe infections European Journal of Hospital Pharmacy
- 2023
- Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program European Journal of Pediatrics
- 2022
- Factors Associated with Plasma Levels of Tamoxifen and its Main Metabolites in Mexican Patients with Breast Cancer Current Pharmacogenomics and Personalized Medicine
- Disease activity and therapeutic drug monitoring of polyglutamates of methotrexate after daily or weekly administration of low‐dose methotrexate in patients recently diagnosed with rheumatoid arthritis Basic & Clinical Pharmacology & Toxicology
- 2021
- Optimizing Meropenem Therapy for Severe Nosocomial Infections in Neonates Journal of Pharmaceutical Sciences
- 2020
- Population pharmacokinetics of mycophenolic acid in adult kidney transplant patients under prednisone and tacrolimus regimen European Journal of Pharmaceutical Sciences
- Population Pharmacokinetics of Amikacin Administered Once Daily in Patients with Different Renal Functions Antimicrobial Agents and Chemotherapy
- Population pharmacokinetics of methotrexate in Mexican pediatric patients with acute lymphoblastic leukemia Cancer Chemotherapy and Pharmacology
- A population approach of rifampicin pharmacogenetics and pharmacokinetics in Mexican patients with tuberculosis Tuberculosis
